Angle H1 Pre-tax Loss Widens, Lowers FY25 Guidance; Stock Down

(RTTNews) - Angle plc (AGL.L), a London medical diagnostic company, on Tuesday reported a wider pre-tax loss in the first half, hurt by weak revenue and higher operating costs. However, loss per share was narrower than the prior year.

Looking forward to fiscal year 2025, the company affirmed that if the delay to new projects persists in the second half, the expected 2025 revenue is to be 1.5 million pounds less than the earlier guidance, and the excess revenue expectation will shift into 2026.

In the London Stock Exchange, the shares were trading 32.70% lower at 3.87 pence.

Loss before tax widened to 9.73 million pounds from 8.26 million pounds a year ago.

Loss for the period expanded to 9.27 million pounds from 7.71 million pounds in the prior year.

However, loss on a per share basis narrowed to 2.87 pence from a loss of 2.89 pence a year ago.

Revenue shrank to 0.80 million pounds from 1.03 million pounds last year. The revenue was lower than expected, attributed to factors including limited access to capital, US policy volatility, and uncertainty over tariffs for both pharma and medtech companies.